BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27779701)

  • 1. Downregulation of microRNA‑574 in cancer stem cells causes recurrence of prostate cancer via targeting REL.
    Lai X; Guo Y; Guo Z; Liu R; Wang X; Wang F
    Oncol Rep; 2016 Dec; 36(6):3651-3656. PubMed ID: 27779701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of microRNA-328 Functions as a Biomarker for Recurrence of Early Gastric Cancer (EGC) After Endoscopic Submucosal Dissection (ESD) by Modulating CD44.
    Xue HG; Yang AH; Sun XG; Lu YY; Tian ZB
    Med Sci Monit; 2016 Dec; 22():4779-4785. PubMed ID: 27923017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rs4938723 Polymorphism Reduces Expression of MicroRNA-34b and Increases the Risk of Recurrence after Endoscopic Dissection in Early Gastric Cancer.
    Yu K
    Cell Physiol Biochem; 2017; 43(3):1235-1246. PubMed ID: 28977792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of micro-143-3p and BALBP1 contributes to the pathogenesis of the development of ovarian carcinoma.
    Zhang H; Li W
    Oncol Rep; 2016 Dec; 36(6):3605-3610. PubMed ID: 27748916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer.
    Li SL; Sui Y; Sun J; Jiang TQ; Dong G
    Int J Mol Med; 2018 Apr; 41(4):2429-2433. PubMed ID: 29393367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-Regulation of MicroRNA-133b Suppresses Apoptosis of Lens Epithelial Cell by Up-Regulating BCL2L2 in Age-Related Cataracts.
    Zhang F; Meng W; Tong B
    Med Sci Monit; 2016 Nov; 22():4139-4145. PubMed ID: 27802259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Expression of microRNA-9 Contributes to Development of Intracranial Aneurysm by Suppressing Proliferation and Reducing Contractility of Smooth Muscle Cells.
    Luo J; Jin H; Jiang Y; Ge H; Wang J; Li Y
    Med Sci Monit; 2016 Nov; 22():4247-4253. PubMed ID: 27824808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
    Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A
    Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of microRNA‑23b‑3p contributes to the development of intracranial aneurysms by targeting phosphatase and tensin homolog.
    Guo D; Wang YW; Yan L; Ma J; Han XW; Shui SF
    Int J Mol Med; 2018 Sep; 42(3):1637-1643. PubMed ID: 29845190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII.
    Zhang W; Liu J; Qiu J; Fu X; Tang Q; Yang F; Zhao Z; Wang H
    Oncol Rep; 2016 Dec; 36(6):3707-3715. PubMed ID: 27748848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
    Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells.
    Ouyang Y; Gao P; Zhu B; Chen X; Lin F; Wang X; Wei J; Zhang H
    Mol Med Rep; 2015 Feb; 11(2):1435-41. PubMed ID: 25351256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
    Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
    J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer.
    Li X; Liu Y; Chen W; Fang Y; Xu H; Zhu HH; Chu M; Li W; Zhuang G; Gao WQ
    Oncotarget; 2014 Oct; 5(19):9498-513. PubMed ID: 25237769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1.
    Xu B; Huang Y; Niu X; Tao T; Jiang L; Tong N; Chen S; Liu N; Zhu W; Chen M
    Prostate; 2015 Dec; 75(16):1896-903. PubMed ID: 26306811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
    Wang Z; Xue Y; Wang P; Zhu J; Ma J
    Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
    John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
    Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of invasion and migration of prostate cancer cells by miRNA-509-5p via targeting MDM2.
    Tian XM; Luo YZ; He P; Li J; Ma ZW; An Y
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer.
    Hart M; Wach S; Nolte E; Szczyrba J; Menon R; Taubert H; Hartmann A; Stoehr R; Wieland W; Grässer FA; Wullich B
    FEBS J; 2013 May; 280(9):2105-16. PubMed ID: 23480797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.